CD274 and melanoma: The 29‐mer peptide, aunp‐12, developed jointly by Pierre Fabre and Aurigene Discovery Technologies Limited, can target PD‐1/PD‐L1 immune checkpoints, and could inhibit the growth of melanoma cells by 44% in a b6f0 mouse model.80